Patents by Inventor Carlos Rabito

Carlos Rabito has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030215391
    Abstract: A fluorescent agent for monitoring organ function, such as glomerular filtration, renal blood flow, or hepatic function. The agent is injected into a subject and the fluorescence monitored in vivo via time resolved fluorescent techniques. The agent is a lanthanide ion chelated to a polyaminopolyacetic acid analog. A new clearance agent is also proposed based on a tetraazamacrocycle. Such a clearance agent also finds applications in other fields where fluorescence detection is exploited.
    Type: Application
    Filed: May 6, 2003
    Publication date: November 20, 2003
    Inventor: Carlos Rabito
  • Publication number: 20030017111
    Abstract: A fluorescent agent for monitoring organ function, such as glomerular filtration, renal blood flow, or hepatic function. The agent is injected into a subject and the fluorescence monitored in vivo via time-resolved fluorescent techniques. The agent is a lanthanide ion chelated to a polyaminopolyacetic acid analog. A new clearance agent is also proposed based on a tetraazamacrocycle. Such a clearance agent also finds applications in other fields where fluorescence detection is exploited.
    Type: Application
    Filed: August 26, 2002
    Publication date: January 23, 2003
    Inventor: Carlos Rabito
  • Patent number: 6440389
    Abstract: A fluorescent agent for monitoring organ function, such as glomerular filtration, renal blood flow, or hepatic function. The agent is injected into a subject and the fluorescence monitored in vivo via time-resolved fluorescent techniques. The agent is a lanthanide ion chelated to a polyaminopolyacetic acid analog. A new clearance agent is also proposed based on a tetraazamacrocycle. Such a clearance agent also finds applications in other fields where fluorescence detection is exploited.
    Type: Grant
    Filed: August 2, 2000
    Date of Patent: August 27, 2002
    Assignee: The General Hospital Corporation
    Inventor: Carlos Rabito
  • Patent number: 5647363
    Abstract: Accurate and continuous monitoring of clearance function is obtained by determining the depletion of a labelled substance from the extracellular body fluid using an external monitor which detects from within the defined tissue volume. The detector of the external monitor is contained within a barrier which functions to both exclude external influences and to functionally isolate the volume of extracellular fluid to be monitored.
    Type: Grant
    Filed: April 11, 1994
    Date of Patent: July 15, 1997
    Assignee: The General Hospital Corporation
    Inventors: Carlos A. Rabito, Richard H. Moore
  • Patent number: 5301673
    Abstract: Accurate and continuous monitoring of clearance function is obtained by determining the depletion of a labelled substance from the extracellular body fluid using an external monitor which detects label from within a defined tissue volume. The detector of the external monitor is contained within a collimator which functions to both exclude external influences and to functionally isolate the volume of extracellular fluid to be monitored. Also, a method for determining and expressing a clearance function in a subject includes steps of allowing a time sufficient to permit establishment of equilibrium of a detectable substance in the extracellular space in the subject, obtaining first and second measures, at first and second times, of the detectable substance in the extracellular fluid within a defined tissue volume in the subject, and determining the slope of the measures over the time interval.
    Type: Grant
    Filed: November 18, 1991
    Date of Patent: April 12, 1994
    Assignee: Massachusetts General Hospital
    Inventors: Carlos A. Rabito, Richard H. Moore